Boston Scientific Corporation (LON:0HOY)
Market Cap | 115.04B |
Revenue (ttm) | 13.38B |
Net Income (ttm) | 1.48B |
Shares Out | n/a |
EPS (ttm) | 1.00 |
PE Ratio | 77.72 |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 50 |
Average Volume | 11,375 |
Open | 100.40 |
Previous Close | 101.61 |
Day's Range | 99.55 - 100.40 |
52-Week Range | 47.37 - 100.40 |
Beta | 0.77 |
RSI | 45.61 |
Earnings Date | Apr 25, 2025 |
About Boston Scientific
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates in two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention portfolios; devices ... [Read more]
Financial Performance
In 2024, Boston Scientific's revenue was $16.75 billion, an increase of 17.61% compared to the previous year's $14.24 billion. Earnings were $1.85 billion, an increase of 18.03%.
Financial numbers in USD Financial StatementsNews
Medical Products Leader Tops These Early-Bird Buy Points
Boston Scientific has the highest Composite Rating of 126 companies in the medical products industry.
Boston Scientific: Bright Future, Rather Pricey

Low-beta growth stocks to ride out the Trump roller coaster, according to Trivariate Research
Buying low-beta stocks such as Mastercard and Boston Scientific could help improve portfolio performance, Trivariate Research said.
Boston Scientific Corporation (BSX) TD Cowen 45th Annual Healthcare Conference (Transcript)
Boston Scientific (BSX) Acquires SoniVie to Expand Cardiovascular Treatments
Boston Scientific (BSX) Acquires SoniVie to Expand Cardiovascular Treatments
Boston Scientific to acquire SoniVie for $360M upfront payment

Boston Scientific announces agreement to acquire SoniVie Ltd.
Acquisition to expand Interventional Cardiology Therapies offerings with ultrasound-based renal denervation therapy for treatment of hypertension MARLBOROUGH, Mass. , March 3, 2025 /PRNewswire/ -- Bos...
Boston Scientific (BSX) Announces Successful Pricing and Completion of â¬1. ...
Boston Scientific (BSX) Announces Successful Pricing and Completion of â¬1.5 Billion Senior Notes Offering

Boston Scientific announces completion of €1.5 billion offering of senior notes
MARLBOROUGH, Mass. , Feb. 26, 2025 /PRNewswire/ -- Boston Scientific Corporation (the "Company") (NYSE: BSX) today announced that American Medical Systems Europe B.V. ("AMS Europe"), its wholly owned...

Boston Scientific announces completion of €1.5 billion offering of senior notes
MARLBOROUGH, Mass. , Feb. 26, 2025 /PRNewswire/ -- Boston Scientific Corporation (the "Company") (NYSE: BSX) today announced that American Medical Systems Europe B.V.

$1000 Invested In Boston Scientific 10 Years Ago Would Be Worth This Much Today
Boston Scientific (NYSE: BSX) has outperformed the market over the past 10 years by 8.74% on an annualized basis producing an average annual return of 19.64%. Currently, Boston Scientific has a marke...
Boston Scientific Corp (BSX) Trading Down 4.78% on Feb 25
Boston Scientific Corp (BSX) Trading Down 4.78% on Feb 25
Ellen Zane Sells 13,586 Shares of Boston Scientific Corp (BSX)
Ellen Zane Sells 13,586 Shares of Boston Scientific Corp (BSX)

Balloon Catheters Patent Landscape Report 2025, with Profiles of Cook Medical Technologies, Boston Scientific Scimed, Scimed Life Systems, Terumo Corp and Advanced Cardiovascular System
Dublin, Feb. 24, 2025 (GLOBE NEWSWIRE) -- The "Balloon Catheters Patent Landscape Report" has been added to ResearchAndMarkets.com's offering.
Boston Scientific Corp (BSX) Announces â¬1.5 Billion Senior Notes Offering
Boston Scientific Corp (BSX) Announces â¬1.5 Billion Senior Notes Offering

Boston Scientific announces pricing of €1.5 billion of senior notes
MARLBOROUGH, Mass. , Feb. 21, 2025 /PRNewswire/ -- Boston Scientific Corporation (the "Company") (NYSE: BSX) today announced that American Medical Systems Europe B.V.

Boston Scientific announces pricing of €1.5 billion of senior notes
MARLBOROUGH, Mass. , Feb. 21, 2025 /PRNewswire/ -- Boston Scientific Corporation (the "Company") (NYSE: BSX) today announced that American Medical Systems Europe B.V. ("AMS Europe"), its wholly owned ...

Boston Scientific to participate in TD Cowen's 45th Annual Health Care Conference
MARLBOROUGH, Mass. , Feb. 19, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in TD Cowen's 45th Annual Health Care Conference on Tuesday, March 4, 2025.
Beyond the Balance Sheet: What SWOT Reveals About Boston Scientific Corp (BSX)
Beyond the Balance Sheet: What SWOT Reveals About Boston Scientific Corp (BSX)

Sell Alert: EDWARD LUDWIG Cashes Out $1.27M In Boston Scientific Stock
Making a noteworthy insider sell on February 13, EDWARD LUDWIG , Director at Boston Scientific (NYSE: BSX), is reported in the latest SEC filing. What Happened: After conducting a thorough analysis, ...
Boston Scientific Corporation (BSX) Announces Board Member Departure
Boston Scientific Corporation (BSX) Announces Board Member Departure

What's Behind The 130% Rise In BSX Stock?
Boston Scientific stock (NYSE: BSX) has gained 3% in the five days since its Q4 earnings report last week. Although the company exceeded expectations with both its results and guidance, the modest sto...
Insider Sell Alert: John Sorenson Sells Shares of Boston Scientific Corp (BSX)
Insider Sell Alert: John Sorenson Sells Shares of Boston Scientific Corp (BSX)
Boston Scientific targets 12%-14% EPS growth for 2025 with strong FARAPULSE and WATCHMAN momentum
Boston Scientific Corporation (BSX) Q4 2024 Earnings Call Transcript
Boston Scientific Corporation (NYSE:BSX) Q4 2024 Earnings Conference Call February 5, 2025 8:00 AM ETCompany ParticipantsJonathan Monson - SVP, IRMichael...